SEC Company Response from Sanara MedTech Inc. (SMTI) (CIK 0000714256) (SMTI) — Dec 30, 2020
Sanara MedTech Inc. (SMTI) (CIK 0000714256)
Date: Dec. 30, 2020 · CIK: 0000714256 · Accession: 0001654954-20-014040
AI Filing Summary & Sentiment
File numbers found in text: 333-251652
Letter
smti_corresp
Sanara MedTech Inc.
1200 Summit Ave, Suite 414
Fort Worth, Texas 76102
December 30, 2020
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Washington, D.C. 20549
Attention: Tim Buchmiller
Re:
Sanara MedTech Inc.Registration Statement on Form S-3
Filed on December 23, 2020
File No. 333-251652 (the “Registration Statement”)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 of the Rules and Regulations of the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended, Sanara MedTech Inc. (the “Company”) hereby respectfully requests acceleration of the effective date of the Registration Statement so that it may become effective at 4:00 p.m., Eastern Time, on January 4, 2021, or as soon thereafter as practicable.
Should any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Haynes and Boone, LLP, attention: Matthew L. Fry, Esq. at (214) 651-5443.
Very
truly yours,
SANARA
MEDTECH INC.
Show Raw Text
CORRESP 1 filename1.htm smti_corresp Sanara MedTech Inc. 1200 Summit Ave, Suite 414 Fort Worth, Texas 76102 December 30, 2020 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Washington, D.C. 20549 Attention: Tim Buchmiller Re: Sanara MedTech Inc.Registration Statement on Form S-3 Filed on December 23, 2020 File No. 333-251652 (the “Registration Statement”) Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 of the Rules and Regulations of the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended, Sanara MedTech Inc. (the “Company”) hereby respectfully requests acceleration of the effective date of the Registration Statement so that it may become effective at 4:00 p.m., Eastern Time, on January 4, 2021, or as soon thereafter as practicable. Should any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Haynes and Boone, LLP, attention: Matthew L. Fry, Esq. at (214) 651-5443. Very truly yours, SANARA MEDTECH INC. By: /s/ Michael D. McNeil Michael D. McNeil Chief Financial Officer cc: Matthew L. Fry, Esq., Haynes and Boone, LLP